In the presence of cancer cells, fibroblasts phenotypically switch to cancer-associated fibroblasts (CAF), marked by a decrease in expression and functional pro-tumour alterations of p53 (Arandkar et al., 2018). This evidence concerns the gene TP53 and cancer.